Plain-English translation of NCT06896266 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at patients who have developed a weakened heart muscle (cardiomyopathy) caused by irregular heartbeats (arrhythmia). Researchers want to understand the genetics — the inherited traits — that may make some people more likely to develop this condition. By comparing genes in patients who recover after treatment with those who don't, scientists hope to learn why the heart weakens in some cases and what might predict who will improve.
Right now, doctors can treat irregular heartbeats with procedures like cardioversion or catheter ablation, and many patients' hearts recover. However, some patients don't improve, and we don't fully understand why. This study exists to uncover the genetic differences that might explain who will recover and who won't — information that could help doctors predict outcomes and personalize treatment in the future.
You likely qualify if…
You likely don't qualify if…
You will be followed for one year after your heart rhythm treatment. During this time, you'll have visits at 2 months, 6 months, and 12 months, where doctors will perform heart imaging (ultrasound or other scans) and EKGs to see if your heart has recovered. At some point during the study, you'll have a genetic test — usually a simple blood draw — to look for genetic variations related to heart disease. The study team will also track any heart-related problems you experience during the year.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Spain
Sponsor
Hospital Universitario 12 de Octubre
Enrollment target
~109 participants
Started
December 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Martín Negreira-Caamaño, MD, PhD
Cardiology department, 12 de Octubre University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.